{"id":"NCT01748448","sponsor":"Universitaire Ziekenhuizen KU Leuven","briefTitle":"Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome","officialTitle":"Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2022-07","completion":"2022-07","firstPosted":"2012-12-12","resultsPosted":"2025-02-17","lastUpdate":"2025-02-17"},"enrollment":436,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cutaneous Malignant Melanoma"],"interventions":[{"type":"DRUG","name":"Vitamin D","otherNames":["D-Cure","Cholecalciferol"]},{"type":"DRUG","name":"Placebo: Oil","otherNames":["Placebo"]}],"arms":[{"label":"Vitamin D","type":"ACTIVE_COMPARATOR"},{"label":"Placebo: Oil","type":"PLACEBO_COMPARATOR"}],"summary":"To assess whether vitamin D supplementation after surgery of a first cutaneous malignant melanoma protects against relapse of the disease.","primaryOutcome":{"measure":"Relapse Free Survival","timeFrame":"study duration maximum 9 years and 7 months or until relapse","effectByArm":[{"arm":"Vitamin D","deltaMin":41,"sd":null},{"arm":"Placebo: Oil","deltaMin":32,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"= 0.324"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":4,"countries":["Belgium","Hungary"]},"refs":{"pmids":["28835228","38913652","38348498","35312026"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":28,"n":218},"commonTop":["Endocrine disorders","Infections and infestations","Musculoskeletal and connective tissue disorders","Respiratory, thoracic and mediastinal disorders","Gastrointestinal disorders"]}}